No products in the cart.
Eleven genes that have been identified with mutations causing disease—namely BRCA1, BRCA2, APC, CDH1, MLH1, MSH6, MUTYH, PALB2, PMS2, RET, TP53—are proved to be related to hereditary cancer syndromes including cancer of the breast, ovaries, endometrium, stomach, colorectal, pancreas, kidney, adrenal myeloma, multiple endocrine neoplasias, prostate, lung, thyroid, cell tumors, paraganglioma, and skin.
(*) Source: Data according to the Institute of Medical Genetics – Gene Solutions research.
Analysis of 17 genes, early detection of 15 genetic cancers.
oncoSure – 17 gen cho 15 bệnh – 6,500,000 ₫
(*) The 5-year survival rate depends on the type of cancer
Analysis of 133 genes, early detection of 30 genetic cancers.
oncoSure – 17 gen cho 15 bệnh – 6,500,000 ₫
(*) The 5-year survival rate depends on the type of cancer
Analysis of 10 genes for early detection of the most common genetic cancers in women: breast, ovarian and colorectal cancer.
PinkCare – 2,500,000 ₫
(*) The 5-year survival rate depends on the type of cancer
Early detection of the hereditary risk of prostate, colorectal, and stomach cancers.
MenCare – 2,500,000 ₫
(*) The 5-year survival rate depends on the type of cancer
Early screening for hypercholesterolemia (or increased blood fat) can prevent coronary and cardiovascular diseases.
GenLDL – 1,900,000 ₫
Office staff
My older sister has ovarian cancer, my aunt died of breast cancer, and my grandfather died of lung cancer. This makes me very worried because I don’t know what kind of cancer I should get checked for. When I was told to get the oncoSure test package, which evaluated for 15 cancers inherited from relatives, it helped me find out that I had the BRCA1 breast cancer gene. I came up with a plan after talking to a geneticist about how to start improving my health and get regular cancer screenings. It has been five years now, and I’m delighted with healthy living without signs of cancer.
Business manager
A friend recommended the oncoSure Plus genetic cancer testing package to me to learn about the risk of screening for all 30 hereditary cancers. Even though I don’t have any cancer genes in my family, the doctor still told me to pay more attention to my lifestyle and environment because genes are only one of three factors causing cancer.
Cancer screening by genetic testing represents a remarkable development of biomedicine. This is a great opportunity for cancer patients when cancers can be detected at an early stage and not become a death sentence. If the disease is detected at a late stage, the survival rate is reduced fourfold.
In the context of the COVID-19 pandemic, cancer screening with genetic testing is a reminder that cancer patients need to keep up a routine of regular check-ups and early screening. This plays a very important role in improving the recovery rate. Cooperation with medical institutions across the country is needed to spread knowledge about the disease, value, and the benefits of early screening.
When finding out that you have a mutated gene leading to cancer, it’s necessary to guide your family members to undergo their own cancer screening by doing genetic testing for timely and effective treatment at the early stages.
The introduction of the NIPT test helps to reduce not only invasive interventions but also the financial strain on the healthcare industry and the anxiety experienced by couples regarding mother and baby care.
Vietnamese scientists are competent in applying modern genetic sequencing technology. Many pregnant women visiting Hung Vuong Hospital are able to take NIPT tests at a much more reasonable price than before. In addition, a 5–7 day lead time for returning results helps shorten the waiting time and reduce risks and anxiety during pregnancy, especially for the group at high-to-average risk levels.
We employ genetic testing to identify the root causes of inherited cancers (such as breast, ovary, colon, etc.). Healthcare professionals need to consult patients before and after the screening tests to help them understand more about their health condition and make appropriate plans for disease prevention. The fact that patients carry a cancer-causing mutation cannot be changed; however, living a better lifestyle and taking screening to detect cancer early can facilitate patients in their cancer treatment.
Copyright © 2020 GENE SOLUTIONS
Legal Representative: Nguyễn Hữu Nguyên
Enterprise No. 0314215140 – HCMC D.P.I issued on January 23, 2017
| Scope of the test |
 |
 |
 |
 |
 |
 |
|---|---|---|---|---|---|---|
| 3 genes | 10 genes | 10 genes | 17 genes | 133 genes | 65 genes | |
| Breast Cancer | ||||||
| Ovarian Cancer | ||||||
| Colorectal Cancer | ||||||
| Skin Cancer | ||||||
| Lung Cancer | ||||||
| Pancreatic Cancer | ||||||
| Stomach Cancer | ||||||
| Kidney Cancer | ||||||
| Endometrial Cancer | ||||||
| Prostate Cancer | ||||||
| Neural paraganglioma | ||||||
| Thyroid Cancer | ||||||
| Multiple Endocrine Neoplasias | ||||||
| Adrenal Myeloma | ||||||
| Retinoblastoma | ||||||
| Acute Leukemia (blood cancer) | ||||||
| Bladder Cancer | ||||||
| Head and Neck Cancer | ||||||
| Brain Cancer | ||||||
| Biliary Tract Cancer | ||||||
| Bone Cancer | ||||||
| Sarcoma | ||||||
| Liver Cancer | ||||||
| Small Bowel Cancer | ||||||
| Pituitary Tumor | ||||||
| Neuroblastoma | ||||||
| Nerve Fibroma | ||||||
| Parathyroid Cancer | ||||||
| Esophageal Cancer | ||||||
| Multiple Myeloma | ||||||
| Adrenocortical tumors | ||||||
| Central nervous system tumors | ||||||
| Tuberous sclerosis complex | ||||||
| 05 connective tissue diseases | ||||||
| 20 cardiovascular diseases | ||||||
| 09 common recessive diseases | ||||||
| 05 endocrine-metabolic diseases | Familial hypercholesterolemia |
GET MEDICAL CONSULTATION FROM DOCTORS
Tư vấn di truyền
